Welcome to Rusling group’s website!
Our research team employs analytical chemistry, electrochemistry, biochemistry, and nanoscience to develop devices for multiplexed diagnostic, toxicity screening, and new approaches to electrochemical synthesis in water-based microemulsions. A major focus of our current research is designing low cost, high throughput bioanalytical devices, often using microfluidics and 3D printing, for cancer diagnostics, genotoxicity chemistry screening, and electrochemical biocatalysis. We utilize many analytical techniques including electrochemistry, electrochemiluminescence, surface plasmon resonance, and LC-MS/MS. New projects include development of fast, reliable, low cost tests for coronavirus detection. New electrosynthetic approaches feature development of stable biocatalytic films of oxidative enzymes and polyions that can be used at temperatures close up to 95 oC.
We collaborate with a large network of health centers and hospitals, here in Connecticut, and in the US, Canada, Italy, and Ireland in attempt to bring our diagnostic systems to the clinic. We also partner with other faculty from chemistry and material science departments at UCONN to investigate new nanomaterials for the next generation of high throughput biomedical arrays. Current funding sources include NIH, EPA, and NSF.
Professor James F. Rusling
Paul Krenicki Professor of Chemistry
University of Connecticut
Department of Chemistry, U-3060
55 N. Eagleville Rd.
Storrs, CT 06269-3060
Fax: +1 (860) 486-2981
NIH’s Office of Research on Women’s Health recently published Women’s Health in Focus at NIH, Volume 4, Issue 1, that features a recent breast cancer diagnostic device developed by our research group in collaboration with Prof. Colleen Krause (Uconn Ph.D., 2015) at Hartford University Read Women’s Health in Focus at NIH at https://orwh.od.nih.gov/about/newsroom/orwh-quarterly-publication[Read More]
Dr. Snehasis Bhakta, who graduated as a PhD. from our group in 2017, was recently appointed Assistant Professor at Cooch Behar College, Cooch Behar Panchanan Barma University, WB, India[Read More]
Dr. Besnik Bajrami who graduated in 2009 from our group was recently appointed Laboratory Head for Biomarker Discovery at Boehringer Ingelheim in Germany.[Read More]